[Research progress on the pathogenesis mechanism and therapeutic strategies of DCX mutants]

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• The doublecortin (DCX) gene is essential for normal brain development, encoding a protein critical for microtubule function.
• Variants in the DCX gene can impair microtubule dynamics, intracellular transport, and protein modifications, leading to neurological disorders.
• Clinical severity often correlates with the specific type of DCX variant.

Purpose of the Study:

• To summarize the pathogenic mechanisms underlying DCX variants.
• To review current and emerging therapeutic strategies for DCX-related disorders.
• To provide insights for future clinical treatment of these conditions.

Main Methods:

• Review of existing literature on DCX gene variants and associated neurological conditions.
• Analysis of data from animal models and induced pluripotent stem cell (iPSC) models of DCX deficiency.
• Examination of the correlation between DCX variant types and clinical presentation.

Main Results:

• DCX variants disrupt microtubule binding, stabilization, and intracellular transport, impacting brain development.
• Disease progression in DCX deficiency can be dynamically studied using advanced cellular and animal models.
• These models serve as valuable tools for investigating disease mechanisms and screening potential therapeutics.

Conclusions:

• Currently, no cure exists for DCX variants; treatment focuses on anti-epileptic drugs and symptom management.
• Basic research into pathogenic mechanisms and therapeutic strategies offers promising future treatment avenues.
• Understanding DCX variant pathology is crucial for developing effective clinical interventions.